Although several agents showed some clinical activity in patients with recurrent thymoma, there is no standard treatment option. Here, we report a late relapse thymoma and pure red cell aplasia case, responsive to everolimus with over 5 years of clinical benefit following multiple lines of treatment. Everolimus controlled the rapidly progressive disease in our patient without significant toxicity.

中文翻译：

---

晚期复发性胸腺瘤和纯红细胞再生障碍性病例，在依维莫司治疗下具有超过 5 年的临床反应。

尽管几种药物在复发性胸腺瘤患者中表现出一定的临床活性，但没有标准的治疗选择。在此，我们报告一例晚期复发性胸腺瘤和纯红细胞再生障碍性贫血病例，该病例对依维莫司有反应，经过多线治疗后具有超过 5 年的临床获益。依维莫司控制了该患者快速进展的疾病，且没有明显的毒性。